Prognostic factors for positive immune thrombocytopenic purpura outcome after laparoscopic splenectomy

被引:1
作者
Kiudelis, Mindaugas [1 ]
Mickevicius, Antanas [1 ]
Dambrauskiene, Ruta [2 ]
Gerbutavicius, Rolandas [2 ]
Griniute, Rasa [2 ]
Adukauskiene, Dalia [3 ]
机构
[1] Kaunas Univ Med, Surg Clin, LT-44307 Kaunas, Lithuania
[2] Kaunas Univ Med, Clin Hematol, LT-44307 Kaunas, Lithuania
[3] Kaunas Univ Med, Clin Intens Care, LT-44307 Kaunas, Lithuania
来源
CENTRAL EUROPEAN JOURNAL OF MEDICINE | 2011年 / 6卷 / 01期
关键词
Licorice; Laparoscopic splenectomy; ITP; platelet count; ANTI-CD20; MONOCLONAL-ANTIBODY; TERM-FOLLOW-UP; DANAZOL THERAPY; ADULT PATIENTS; RITUXIMAB; MANAGEMENT; AGE; CHILDREN; EFFICACY; RISK;
D O I
10.2478/s11536-010-0063-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Laparoscopic splenectomy is considered as a second step treatment for ITP patients. The purpose of this study was to determine efficiency of laparoscopic splenectomy for ITP patients and to identify the independent prognostic factors that may predict the positive outcome. Two hundred and thirty nine patient medical records were analyzed retrospectively. The special questionnaire, which included present platelet count, the steroid usage and its dosage, was sent to all patients. The complete response (CR) was defined, when the platelet count was above 130 x 109 /L. The 239 adult patients with a median age of 51.3 (16-93 years) were included in this cohort. The median follow up period was 75 months. 49 patients, who relapsed after steroid treatment, underwent laparoscopic splenectomy. The short term postoperative CR was 71.4% after laparoscopic splenectomy compared to 38.1% in non-splenectomized patients (p < 0.000). The long term CR was 79.5 % in patients after splenectomy compared to 47.4% in non-splenectomized patients (p < 0.018). After univaried analysis three clinical variables were found to be significantly related to splenectomy outcome: disease duration (p < 0.007), preoperative platelet count (p < 0.049) and platelet count on the third postoperative day (p < 0.000). Multiple logistic regression analysis demonstrated, that only platelet count on the 3rd postoperative day > 129 x 109 /L; RR=53.3 95% (CI, 1.888-1517.98) was significant predictor for long-term positive ITP outcome after laparoscopic splenectomy. Splenectomy is effective treatment for ITP. Platelet count > 129 x 109/L on the third postoperative day is the significant predictor of positive long-term outcome after laparoscopic splenectomy.
引用
收藏
页码:123 / 130
页数:8
相关论文
共 50 条
[1]   LONG-TERM DANAZOL THERAPY IN AUTOIMMUNE THROMBOCYTOPENIA - UNMAINTAINED REMISSION AND AGE-DEPENDENT RESPONSE IN WOMEN [J].
AHN, YS ;
ROCHA, R ;
MYLVAGANAM, R ;
GARCIA, R ;
DUNCAN, R ;
HARRINGTON, WJ .
ANNALS OF INTERNAL MEDICINE, 1989, 111 (09) :723-729
[2]  
AKSNES J, 1995, EUR J SURG, V161, P253
[3]  
Alpdogan O, 1998, BRIT J HAEMATOL, V103, P1961
[4]   Idiopathic thrombocytopenic purpura -: A retrospective analysis in 139 patients of the influence of age on the response to corticosteroids, splenectomy and danazol [J].
Andrès, E ;
Zimmer, J ;
Noel, E ;
Kaltenbach, G ;
Koumarianou, A ;
Maloisel, F .
DRUGS & AGING, 2003, 20 (11) :841-846
[5]  
[Anonymous], 2008, SURG ENDOSC, V22, P821
[6]  
Blanchette V, 1998, SEMIN HEMATOL, V35, P36
[7]   Long-term follow-up of chronic autoimmune thrombocytopenic purpura refractory to splenectomy: a prospective analysis [J].
Bourgeois, E ;
Caulier, MT ;
Delarozee, C ;
Brouillard, M ;
Bauters, F ;
Fenaux, P .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (06) :1079-1088
[8]   Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura [J].
Brændstrup, P ;
Bjerrum, OW ;
Nielsen, OJ ;
Jensen, BA ;
Clausen, NT ;
Hansen, PB ;
Andersen, I ;
Schmidt, K ;
Andersen, TM ;
Peterslund, NA ;
Birgens, HS ;
Plesner, T ;
Pedersen, BB ;
Hasselbalch, HC .
AMERICAN JOURNAL OF HEMATOLOGY, 2005, 78 (04) :275-280
[9]   Long-term dosing of AMG 531 in thrombocytopenic patients with immune thrombocytopenic purpura: 2-year update [J].
Bussel, James B. ;
Kuter, D. J. ;
de Wolf, J. Th. M. ;
Guthrie, T. H. ;
Newland, A. ;
Wasser, J. S. ;
Hamburg, S. I. ;
Bjorkquist, L. ;
Guo, M. ;
Nichol, J. .
BLOOD, 2007, 110 (11) :174A-175A
[10]   Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone. [J].
Cheng, YF ;
Wong, RSM ;
Soo, YOY ;
Chui, CH ;
Lau, FY ;
Chan, NPH ;
Wong, WS ;
Cheng, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (09) :831-836